Pyxis Oncology (PYXS) Institutional Ownership → The CHIPS Act Motherlode (From True Market Insiders) (Ad) Free PYXS Stock Alerts $4.15 -0.02 (-0.48%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Pyxis Oncology (NASDAQ:PYXS)CurrentInstitutional OwnershipPercentage39.09%Number ofInstitutional Buyers(last 12 months)18TotalInstitutional Inflows(last 12 months)$19.83MNumber ofInstitutional Sellers(last 12 months)0 Get PYXS Insider Trade Alerts Want to know when executives and insiders are buying or selling Pyxis Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PYXS Institutional Buying and Selling by Quarter Ad True Market InsidersThe CHIPS Act MotherlodeIf you haven’t heard yet, the CHIPS Act is the US government pouring $280 BILLION into the manufacturing of US semiconductors. A lot of companies will make a fortune from this.Click here to see my #1 investment for 2024. Pyxis Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/17/2024 Ikarian Capital LLC1,662,408$7.08M0.8%N/A2.823% 5/14/2024 StemPoint Capital LP1,794,195$7.64M2.0%N/A3.047% 5/10/2024 Vanguard Group Inc.1,401,425$5.97M0.0%+7.3%2.380% 5/7/2024Susquehanna Fundamental Investments LLC82,447$351K0.0%N/A0.140% 5/7/2024 SG Americas Securities LLC13,809$59K0.0%N/A0.023% 2/20/2024 Cable Car Capital LLC61,606$111K0.1%N/A0.139% Get the Latest News and Ratings for PYXS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pyxis Oncology and its competitors with MarketBeat's FREE daily newsletter. 2/14/2024 Vestal Point Capital LP440,000$792K0.1%N/A0.993% 2/12/2024 Decheng Capital LLC326,810$588K0.2%N/A0.737% 1/31/2024 abrdn plc708,303$1.28M0.0%N/A1.598% 11/29/2023Decheng Capital Management III Cayman LLC326,810$650K0.2%N/A0.737% 11/15/2023 Radcliffe Capital Management L.P.53,288$106K0.0%N/A0.120% 11/14/2023 Schulhoff & Co. Inc.22,000$44K0.0%N/A0.050% 11/13/2023 Acadian Asset Management LLC13,233$26K0.0%N/A0.030% 10/23/2023Commonwealth Equity Services LLC12,950$26K0.0%N/A0.033% 8/14/2023 Prelude Capital Management LLC10,352$27K0.0%N/A0.027% 8/11/2023 Harvest Investment Services LLC116,428$298K0.2%+27.9%0.304% 8/11/2023 ExodusPoint Capital Management LP259,561$664K0.0%+270.8%0.679% 8/10/2023 Cetera Investment Advisers18,260$47K0.0%N/A0.048% 7/10/2023 SG Americas Securities LLC20,497$52K0.0%N/A0.054% 5/16/2023 Hhlr Advisors LTD.530,692$2.13M0.0%-30.6%1.435% 5/4/2023 Barclays PLC118,223$474K0.0%-87.5%0.320% 4/27/2023Simplicity Solutions LLC18,110$73K0.0%N/A0.049% 2/15/2023 Tang Capital Management LLC3,470,700$4.65M0.7%+145.9%9.888% 2/9/2023 Citigroup Inc.357,537$479K0.0%+14.5%1.019% 1/12/2023 Marquette Asset Management LLC58,862$79K0.0%N/A0.168% 11/15/2022 Tang Capital Management LLC1,411,569$2.78M0.3%+2.4%4.022% 11/14/2022 RA Capital Management L.P.764,653$1.51M0.0%-19.8%2.179% 8/15/2022 Acuta Capital Partners LLC645,149$1.54M0.9%+222.6%1.966% 8/15/2022 Laurion Capital Management LP3,170,803$7.55M0.1%+159.9%9.662% 5/16/2022 Ghost Tree Capital LLC75,000$303K0.1%-74.6%0.228% 5/13/2022Tekla Capital Management LLC708,303$2.63M0.1%+424.7%2.157% 2/16/2022 Ghost Tree Capital LLC295,000$3.24M1.2%N/A0.900% 2/15/2022 Laurion Capital Management LP1,162,332$12.75M0.1%N/A3.548% 2/15/2022Davidson Kempner Capital Management LP10,000$109K0.0%N/A0.031% 2/14/2022 Citadel Advisors LLC1,521,617$16.48M0.0%N/A4.644% 2/14/2022 Deerfield Management Company L.P. Series C311,754$3.42M0.1%N/A0.952% 2/14/2022 Hhlr Advisors LTD.764,406$8.39M0.1%N/A2.333% 2/14/2022 Perceptive Advisors LLC1,944,114$21.33M0.3%N/A5.934% 2/14/2022 Sandia Investment Management LP10,000$110K0.0%N/A0.031% 2/14/2022 Ghisallo Capital Management LLC30,000$329K0.0%N/A0.092% The CHIPS Act Motherlode (Ad)If you haven’t heard yet, the CHIPS Act is the US government pouring $280 BILLION into the manufacturing of US semiconductors. A lot of companies will make a fortune from this.Click here to see my #1 investment for 2024.2/8/2022 Northern Trust Corp89,235$979K0.0%N/A0.272% 2/2/2022 New York State Common Retirement Fund6,277$69K0.0%N/A0.019% (Data available from 1/1/2016 forward) PYXS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PYXS shares? During the previous two years, 27 institutional investors and hedge funds held shares of Pyxis Oncology. The most heavily invested institutionals were StemPoint Capital LP ($7.64M), Laurion Capital Management LP ($7.55M), Ikarian Capital LLC ($7.08M), Vanguard Group Inc. ($5.97M), Tang Capital Management LLC ($4.65M), Hhlr Advisors LTD. ($2.13M), and Acuta Capital Partners LLC ($1.54M).Learn more on PYXS's institutional investors. What percentage of Pyxis Oncology stock is owned by institutional investors? 39.09% of Pyxis Oncology stock is owned by institutional investors. Learn more on PYXS's institutional investor holdings. Which institutional investors have been buying Pyxis Oncology stock? Of the 24 institutional investors that purchased Pyxis Oncology stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Tang Capital Management LLC ($2.09M), Laurion Capital Management LP ($1.95M), StemPoint Capital LP ($1.79M), Ikarian Capital LLC ($1.66M), abrdn plc ($708.30K), Acuta Capital Partners LLC ($445.15K), and Vestal Point Capital LP ($440K). How much institutional buying is happening at Pyxis Oncology? Institutional investors have bought a total of 10,486,591 shares in the last 24 months. This purchase volume represents approximately $28.57M in transactions. Which Pyxis Oncology major shareholders have been selling company stock? The following institutional investors have sold Pyxis Oncology stock in the last 24 months: Barclays PLC ($829.83K), Hhlr Advisors LTD. ($233.71K), and RA Capital Management L.P. ($188.74K). How much institutional selling is happening at Pyxis Oncology? Institutional investors have sold a total of 1,252,282 shares in the last 24 months. This volume of shares sold represents approximately $4.64M in transactions. Related Companies: ALDX Major Shareholders OMER Major Shareholders TSVT Major Shareholders GTHX Major Shareholders FHTX Major Shareholders DSGN Major Shareholders QURE Major Shareholders PBYI Major Shareholders IMMP Major Shareholders AKBA Major Shareholders This page (NASDAQ:PYXS) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the Markets[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsDems have chosen Biden replacement?Paradigm PressShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pyxis Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.